Exporter

You can select particular sections to be included in the output file.
EN
FR

Liste modèle des médicaments essentiels

effacer Trouvé 48 recommandations pour 27 médicaments et 7 équivalents thérapeutiques
Les recommandations supprimées et les demandes rejetées sont affichées. Les cacher.
13. Dermatological medicines
  1. Adalimumab Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Parenteral > General injections > SC: 10 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.2 mL mL in pre-filled syringe or pre-filled pen.; 20 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.4 mL mL in pre-filled syringe or pre-filled pen.; 40 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen.; 80 mg per 0.8 mL mL in pre-filled syringe or pre-filled pen.
  2. Benzoic acid + salicylic acid Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Cream: 6% + 3%
    • Local > Topical > Ointment: 6% + 3%
  3. Benzoyl peroxide Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Cream: 5%
    • Local > Topical > Lotion: 5%
    Indications
  4. Benzyl benzoate Informations générales
    Section
    Dermatological medicines > Scabicides and pediculicides
    • Local > Topical > Lotion: 25%
  5. Betamethasone Informations générales
    Section
    Dermatological medicines > Anti-inflammatory and antipruritic medicines
    • Local > Topical > Cream: 0.1% (as valerate)
    • Local > Topical > Ointment: 0.1% (as valerate)
  6. Calamine Informations générales
    Section
    Dermatological medicines > Anti-inflammatory and antipruritic medicines
    • Local > Topical > Lotion:
    Indications
  7. Calcipotriol Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Cream: 50 µg per mL (0.005%)
    • Local > Topical > Lotion: 50 µg per mL (0.005%)
    • Local > Topical > Ointment: 50 µg per mL (0.005%)
  8. Calcitriol Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to calcipotriol pour Psoriasis of unspecified type
  9. Certolizumab pegol Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to adalimumab pour Psoriasis of unspecified type
  10. Ciclopirox Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Solution: 80 mg per g (as hydroxypropyl chitosan)
    Indications
  11. Coal tar Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Solution: 5%
  12. Etanercept Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to adalimumab pour Psoriasis of unspecified type
  13. Fluorouracil Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Ointment: 5%
    Indications
  14. Glycerol Informations générales
    Section
    Dermatological medicines > Moisturizers
    • Local > Topical > Cream: 15 to 20%
    Indications
  15. Hydrocortisone Informations générales
    Section
    Dermatological medicines > Anti-inflammatory and antipruritic medicines
    • Local > Topical > Cream: 1% (acetate)
    • Local > Topical > Ointment: 1% (acetate)
  16. Infliximab Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to adalimumab pour Psoriasis of unspecified type
  17. Lindane Informations générales
    Section
    Dermatological medicines > Scabicides and pediculicides
    • Local > Topical > Cream: 1%
    • Local > Topical > Lotion: 1%
    Indications
  18. Methotrexate Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt)
  19. Miconazole Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Cream: 2% (nitrate)
    • Local > Topical > Ointment: 2% (nitrate)
  20. Mupirocin Informations générales
    Section
    Dermatological medicines > Anti-infective medicines
    • Local > Topical > Cream: 2% (as mupirocin calcium)
    • Local > Topical > Ointment: 2%
  21. Permethrin Informations générales
    Section
    Dermatological medicines > Scabicides and pediculicides
    • Local > Topical > Lotion: 1%
    • Local > Topical > Cream: 5%
  22. Podophyllotoxin Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to podophyllum resin pour Anogenital warts Therapeutic equivalent to podophyllum resin pour Plantar warts
  23. Podophyllum resin Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Solution: 10 to 25%
  24. Potassium permanganate Informations générales
    Section
    Dermatological medicines > Anti-infective medicines
    • Local > Topical > Solution: aqueous solution: 1:10 000
  25. Precipitated sulfur Informations générales
    Section
    Dermatological medicines > Scabicides and pediculicides
    • Local > Topical > Ointment:
    Indications
    Therapeutic equivalent to benzyl benzoate pour Pthiriasis Therapeutic equivalent to benzyl benzoate pour Pediculosis corporis Therapeutic equivalent to benzyl benzoate pour Pediculosis capitis Therapeutic equivalent to benzyl benzoate pour Scabies
  26. Salicylic acid Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Solution: 5%
  27. Selenium sulfide Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Suspension: 2% detergent-based
  28. Silver sulfadiazine Informations générales
    Section
    Dermatological medicines > Anti-infective medicines
    • Local > Topical > Cream: 1%
    Indications
  29. Sodium thiosulfate Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Solution: 15%
  30. Sunscreen, broad-spectrum Informations générales
    Section
    Dermatological medicines
    • Topical cream, lotion, gel, ointment, spray with sun protection factor ≥ 50.
    Section
    Dermatological medicines > Sunscreens
    • Topical:
    • Therapeutic broad-spectrum sunscreens should contain proven active ingredients in appropriate amounts to absorb or filter UVA and UVB radiation, and have a high sun protection factor (SPF).
  31. Tacalcitol Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    Indications
    Therapeutic equivalent to calcipotriol pour Psoriasis of unspecified type
  32. Terbinafine Informations générales
    Section
    Dermatological medicines > Antifungal medicines
    • Local > Topical > Cream: 1% terbinafine hydrochloride
    • Local > Topical > Ointment: 1% terbinafine hydrochloride
  33. Urea Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Local > Topical > Cream: 10%; 5%
    • Local > Topical > Ointment: 10%; 5%
    Section
    Dermatological medicines > Moisturizers
    • Local > Topical > Cream: 5 per %
    Indications
  34. Ustekinumab Informations générales
    Section
    Dermatological medicines > Medicines affecting skin differentiation and proliferation
    • Parenteral > General injections > SC: 45 mg per 0.5 mL in vial; 45 mg per 0.5 mL in pre-filled syringe; 45 mg per 0.5 mL in pre-filled pen; 90 mg per mL in pre-filled syringe; 90 mg per mL in pre-filled pen